FLUPENTIXOLE 0.5 mg+ MELITRACEN 10 mg is a combination of two medicines: Flupenthixol and melitracen. It has been widely used for depression and has been proven not only a rapid onset with an anxiolytic, antidepressant, and activating properties in low doses. This medication may be clinically a reasonable alternative to SSRI treatment, especially in depression with psychotic features. For instance, it is effective with mosapride in treating gastroigastrointestinalers with clonazeclonazepame tinnitus and in treating irritable bowel syndrome. The combination of the two compounds was designed to enhance the pharmacological effect as well as to lower the AE incidents.
Constipation, drowsiness, vision changes, or dry mouth may occur. If any of those effects persist or worsen, notify your consulting doctor. Unlikely to occur, but promptly: restlessness, weakness, muscle stiffness, difficulty speaking. Loss of balance, mask-like facial expression, trembling or shaking.
Very likely to occur, but recently promptly: sore throat, usual bleeding, stomach pain, yellowing of eyes, hot dry skin, etc. Though notify your doctor if you experience any other effects: muscle stiffness.
Storage:
Store this medication at room temperature between 15 to 30 degree Celsius away from heat and light. Do not store in a moistening place. Keep this and all medications out of the reach of children.
Take this medication by mouth exactly as prescribed by your doctor. During the first few days, your doctor may gradually increase your dose to allow your body to adjust the medication. Your condition will not improve any faster but the risk of serious side effects will be increased if you overdosing your medicine without any consultation with a doctor. It may take several weeks for the full benefits of this medicine to take it.
Emocare is a certified company according to ISO, their formulation inspires quality, virtue, and viability to maximum height. Our company wants to spread its blanket of quality and service and highly trusted pharmaceutical franchise offering on a monopoly basis to other arms of our nation to lead pharmaceutical industries’ resonance of excellence. The company has maintained its position in the top 10 Neuropsychiatry companies in India.